Recall D-1303-2022
Description: Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30.
Recall D-1303-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-1303-2022 |
| Event ID | 90635 |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 5677 bottles |
| Recall Reason | Failed Dissolution Specifications: below specification limits for dissolution. |
| Drug Classification | Class II |
| Drug Code Info | 20220810 |
| Recall Initiation Date | 20220721 |
| Report Date | 20220810 |
| Classification Date | 20220804 |
| Address | 400 Interpace Pkwy Bldg A Parsippany, NJ 07054-1120 United States |
| Recalling Firm | Teva Pharmaceuticals USA Inc |
| Similar To |